|
US2737518A
(en)
*
|
1955-01-19 |
1956-03-06 |
Schering Corp |
1-hydroxycortisone, 1-hydroxyhydrocortisone and esters thereof
|
|
US2968655A
(en)
*
|
1956-11-23 |
1961-01-17 |
Upjohn Co |
11-oxygenated-6-methyl progesterone and intermediates therefor
|
|
US2920999A
(en)
|
1957-06-07 |
1960-01-12 |
Pfizer & Co C |
21-nitrogen derivatives of corticosteroids
|
|
GB889766A
(en)
|
1958-03-04 |
1962-02-21 |
Olin Mathieson |
Improvements in steroids and the synthesis thereof
|
|
DE1165595B
(de)
|
1958-03-04 |
1964-03-19 |
Olin Mathieson |
Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen
|
|
US3197469A
(en)
|
1958-08-06 |
1965-07-27 |
Pharmaceutical Res Products In |
16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
|
|
US3007923A
(en)
*
|
1959-01-22 |
1961-11-07 |
Lab Francais Chimiotherapie |
Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
|
|
GB898291A
(en)
|
1959-03-18 |
1962-06-06 |
Upjohn Co |
Improvements in or relating to steroids and the manufacture thereof
|
|
US3033873A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
21-aminomethyl-pregnenes
|
|
US3033874A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
17beta-propenoyl steroids and process for preparing same
|
|
US3020275A
(en)
*
|
1960-06-07 |
1962-02-06 |
American Cyanamid Co |
21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
|
|
DE1169444B
(de)
*
|
1961-02-22 |
1964-05-06 |
Schering Ag |
Verfahren zur Herstellung von ?-16ª-Methylsteroiden
|
|
US3047468A
(en)
*
|
1961-06-06 |
1962-07-31 |
American Cyanamid Co |
Method of preparing delta1, 4-3-keto steroids of the pregnane series
|
|
US3383394A
(en)
*
|
1965-08-30 |
1968-05-14 |
Schering Corp |
Novel 17-acylating process and products thereof
|
|
US3798216A
(en)
|
1969-03-07 |
1974-03-19 |
Fabrication Des Antibiotique S |
9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
|
|
DE2047105C3
(de)
|
1970-09-18 |
1979-02-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
17-Chlorsteroide und Verfahren zu ihrer Herstellung
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
SE378109B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378110B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4076737A
(en)
|
1975-02-20 |
1978-02-28 |
Ciba-Geigy Corporation |
Aldehydes of the pregnane series and derivatives thereof
|
|
IL73337A
(en)
|
1984-10-28 |
1988-09-30 |
Yissum Res Dev Co |
Antitumor steroid-platinum complexes and method for the preparation thereof
|
|
ES8605537A1
(es)
|
1985-07-03 |
1986-02-01 |
Elmu Sa |
Procedimiento de obtencion de cetales ciclicos de corticoi- des y sus 21-c esteres
|
|
SE8604059D0
(sv)
|
1986-09-25 |
1986-09-25 |
Astra Pharma Prod |
A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5116829A
(en)
|
1990-04-23 |
1992-05-26 |
Kao Corporation |
Steroid compounds
|
|
US5183815A
(en)
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
|
ATE255131T1
(de)
|
1991-06-14 |
2003-12-15 |
Genentech Inc |
Humanisierter heregulin antikörper
|
|
ATE183192T1
(de)
|
1993-01-08 |
1999-08-15 |
Astra Ab |
Neue colon-oder ilean-spezifische steroid derivate
|
|
DE4311987A1
(de)
|
1993-04-07 |
1994-10-13 |
Schering Ag |
Neue Glucocorticoide
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US5837698A
(en)
|
1996-05-02 |
1998-11-17 |
G. D. Searle & Co. |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
|
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
SE0101220D0
(sv)
|
2001-04-04 |
2001-04-04 |
Astrazeneca Ab |
New use
|
|
US6908934B2
(en)
|
2001-06-11 |
2005-06-21 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
ITMI20020148A1
(it)
|
2002-01-29 |
2003-07-29 |
Nicox Sa |
Nuovi corticosteroidi
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
ES2544527T3
(es)
|
2002-07-31 |
2015-09-01 |
Seattle Genetics, Inc. |
Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
AU2003265576A1
(en)
|
2002-08-23 |
2004-03-11 |
The Mclean Hospital Corporation |
Corticosteroid conjugates and uses thereof
|
|
EP2277551B1
(en)
|
2002-09-06 |
2013-05-08 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
|
|
CN1414008A
(zh)
|
2002-10-17 |
2003-04-30 |
南开大学 |
含氮甾体化合物及其制备方法
|
|
US7015349B2
(en)
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
|
EP3434275A1
(en)
|
2003-11-06 |
2019-01-30 |
Seattle Genetics, Inc. |
Assay for cancer cells based on the use of auristatin conjugates with antibodies
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
WO2005079523A2
(en)
|
2004-02-18 |
2005-09-01 |
University Of Georgia Research Foundation, Inc. |
Novel teleost derived antimicrobal polypeptides
|
|
US20050192257A1
(en)
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
TW200539855A
(en)
|
2004-03-15 |
2005-12-16 |
Wyeth Corp |
Calicheamicin conjugates
|
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
|
EP1602931A1
(en)
|
2004-06-03 |
2005-12-07 |
Universiteit Leiden |
SR-A antagonists
|
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
ES2315600T3
(es)
|
2004-08-09 |
2009-04-01 |
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Conjugados de albumina que contienen un ligador glucuronico.
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
AU2005316844A1
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
WO2006135371A1
(en)
|
2005-06-09 |
2006-12-21 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
RU2008100237A
(ru)
*
|
2005-06-14 |
2009-07-20 |
Джилид Сайэнс, Инк. (US) |
ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ
|
|
US20070135398A1
(en)
|
2005-11-02 |
2007-06-14 |
Pierluigi Rossetto |
Process for the preparation of ciclesonide
|
|
EP1977252B1
(en)
|
2005-12-22 |
2012-12-05 |
Baxter International Inc. |
Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2008127347A1
(en)
|
2006-07-21 |
2008-10-23 |
Diadexus, Inc. |
Pro115 antibody compositions and methods of use
|
|
US20100041633A1
(en)
|
2007-02-05 |
2010-02-18 |
Nicox S.A. |
Nitric oxide releasing steroids
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
ES2731432T3
(es)
|
2007-05-23 |
2019-11-15 |
Ventana Med Syst Inc |
Transportadores poliméricos para inmunohistoquímica e hibridación in situ
|
|
CN104383553A
(zh)
|
2007-06-25 |
2015-03-04 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
EP2170054A4
(en)
|
2007-06-28 |
2012-08-08 |
Capsutech Ltd |
TARGETING CONJUGATES WITH ACTIVE SUBSTANCES ENCAPLED IN CYCLODEXTRIN POLYMERS
|
|
CN101397328A
(zh)
|
2007-09-27 |
2009-04-01 |
天津药业研究院有限公司 |
一氧化氮供体型糖皮质激素
|
|
EP2214646B1
(en)
|
2007-10-05 |
2021-06-23 |
Wayne State University |
Dendrimers for sustained release of compounds
|
|
AR069804A1
(es)
*
|
2007-12-21 |
2010-02-17 |
Schering Corp |
Agonistas del receptor glucocorticoide c20- c21 sustituido
|
|
CL2008003802A1
(es)
|
2007-12-21 |
2010-02-19 |
Schering Corp |
Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple.
|
|
RU2487877C2
(ru)
|
2008-04-30 |
2013-07-20 |
Иммьюноджен, Инк. |
Высокоэффективные конъюгаты и гидрофильные сшивающие агенты (линкеры)
|
|
US20090318396A1
(en)
|
2008-06-10 |
2009-12-24 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010010324A1
(en)
|
2008-07-21 |
2010-01-28 |
Polytherics Limited |
Novel reagents and method for conjugating biological molecules
|
|
WO2010010119A1
(en)
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
EP2407476B1
(en)
|
2009-03-09 |
2014-05-07 |
Mikasa Seiyaku Co,. Ltd. |
Steroid compound
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
WO2011018613A1
(en)
|
2009-08-10 |
2011-02-17 |
Ucl Business Plc |
Functionalisation of solid substrates
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
GB0917054D0
(en)
*
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
US20110178287A1
(en)
|
2010-01-19 |
2011-07-21 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
US9375473B2
(en)
|
2010-02-19 |
2016-06-28 |
Cornell Research Foundation, Inc. |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
|
WO2011130598A1
(en)
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2012005982A2
(en)
|
2010-07-06 |
2012-01-12 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Reporter for rna polymerase ii termination
|
|
CA2806258A1
(en)
|
2010-07-23 |
2012-01-26 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and application thereof
|
|
KR102306967B1
(ko)
|
2010-08-02 |
2021-10-01 |
리제너론 파아마슈티컬스, 인크. |
Ｖｌ 도메인을 포함하는 결합 단백질을 생성하는 마우스
|
|
WO2012028579A1
(de)
|
2010-09-01 |
2012-03-08 |
Bayer Cropscience Ag |
N-(tetrazol-5-yl)- und n-(triazol-5-yl)arylcarbonsäureamide und ihre verwendung als herbizide
|
|
CN103328505B
(zh)
|
2010-10-29 |
2015-12-02 |
伊缪诺金公司 |
非拮抗性egfr结合分子及其免疫偶联物
|
|
WO2012145632A1
(en)
|
2011-04-21 |
2012-10-26 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
EP2714685B1
(en)
|
2011-05-27 |
2016-10-19 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
MX358757B
(es)
|
2011-10-14 |
2018-09-03 |
Seattle Genetics Inc |
Pirrolobenzodiazepinas y conjugados dirigidos.
|
|
US9102704B2
(en)
|
2011-10-14 |
2015-08-11 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
US9526798B2
(en)
|
2011-10-14 |
2016-12-27 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
SG11201401021TA
(en)
|
2011-10-14 |
2014-08-28 |
Spirogen Sarl |
Pyrrolobenzodiazepines
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
AU2012348017A1
(en)
|
2011-12-05 |
2014-07-03 |
Igenica Biotherapeutics, Inc. |
Antibody-drug conjugates and related compounds, compositions, and methods
|
|
GB201122325D0
(en)
|
2011-12-23 |
2012-02-01 |
Cytoguide As |
Novel formulations
|
|
NZ631565A
(en)
|
2012-03-14 |
2016-07-29 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
AU2013274078A1
(en)
|
2012-06-14 |
2015-01-29 |
Ambrx, Inc. |
Anti-PSMA antibodies conjugated to nuclear receptor ligand polypeptides
|
|
BR112015007814B1
(pt)
|
2012-10-11 |
2022-04-19 |
Ascendis Pharma A/S |
Uso de profármaco polimérico no diagnóstico, prevenção e tratamento de doenças da articulação
|
|
JP2015536323A
(ja)
|
2012-10-16 |
2015-12-21 |
エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． |
非天然アミノ酸を含む薬物送達結合体および使用方法
|
|
ES2659270T5
(en)
|
2012-10-23 |
2026-02-11 |
Synaffix Bv |
Modified antibody, antibody-conjugate and process for the preparation thereof
|
|
WO2014065575A1
(ko)
|
2012-10-25 |
2014-05-01 |
주식회사유한양행 |
4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
|
|
EP2935331B1
(en)
|
2012-12-24 |
2018-02-28 |
AbbVie Inc. |
Prolactin receptor binding proteins and uses thereof
|
|
SG11201506372RA
(en)
|
2013-03-13 |
2015-09-29 |
Seattle Genetics Inc |
Cyclodextrin and antibody-drug conjugate formulations
|
|
HK1222122A1
(zh)
|
2013-04-22 |
2017-06-23 |
Avelas Biosciences, Inc. |
选择性药物递送组合物及使用方法
|
|
ES2759503T3
(es)
|
2013-05-02 |
2020-05-11 |
Glykos Finland Oy |
Conjugados de una glicoproteína o un glicano con una carga útil tóxica
|
|
WO2014197854A1
(en)
|
2013-06-06 |
2014-12-11 |
Igenica Biotherapeutics, Inc. |
Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
JP6744212B2
(ja)
|
2013-06-21 |
2020-08-19 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
ポリペプチドの酵素的結合
|
|
US20160158369A1
(en)
|
2013-07-10 |
2016-06-09 |
Seikagaku Corporation |
Pharmaceutical composition for respiratory administration
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
AU2014337555C1
(en)
|
2013-10-15 |
2021-01-28 |
Seagen Inc. |
PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics
|
|
GB201320091D0
(en)
|
2013-11-14 |
2014-01-01 |
Univ Manchester |
Selective glucocorticoid receptor ligands
|
|
CN103694375B
(zh)
|
2013-12-13 |
2016-10-05 |
北京大学 |
一种三萜-环糊精共价化合物及其制备方法和用途
|
|
JP6527171B2
(ja)
|
2014-01-24 |
2019-06-05 |
サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック |
クローン病などの大腸菌誘発性炎症性腸疾患治療用の経口摂取可能な化合物、これを調製するプロセスおよび付着防止薬としての使用
|
|
EP3125943B1
(en)
|
2014-04-04 |
2026-04-22 |
Merck Sharp & Dohme LLC |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
CN111228511B
(zh)
|
2014-04-10 |
2024-06-18 |
第一三共株式会社 |
抗her3抗体-药物偶联物
|
|
FI3166638T3
(fi)
|
2014-06-13 |
2025-09-17 |
Glykos Finland Oy |
Hyötykuorma-polymeeri-proteiini konjugaatteja
|
|
KR20170086536A
(ko)
|
2014-12-03 |
2017-07-26 |
제넨테크, 인크. |
항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도
|
|
JP6751393B2
(ja)
|
2014-12-03 |
2020-09-02 |
ジェネンテック， インコーポレイテッド |
抗ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ抗体リファマイシン抱合体及びその使用
|
|
US20160158377A1
(en)
|
2014-12-09 |
2016-06-09 |
Abbvie Inc. |
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
|
|
CN111620861A
(zh)
|
2014-12-09 |
2020-09-04 |
艾伯维公司 |
具有低细胞渗透性的bcl-xl抑制性化合物以及包括它的抗体药物缀合物
|
|
WO2016120891A1
(en)
|
2015-01-30 |
2016-08-04 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
EP3253212A4
(en)
|
2015-02-06 |
2018-09-19 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
MY189159A
(en)
|
2015-07-06 |
2022-01-29 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
WO2017006279A1
(en)
|
2015-07-08 |
2017-01-12 |
Aten Porus Lifesciences |
Cyclodextrin-polymer complexes and compostions and methods of making and using the same
|
|
JP6823067B2
(ja)
|
2015-09-10 |
2021-01-27 |
タンボ・インコーポレイテッド |
生体直交型組成物
|
|
EP3359194A4
(en)
|
2015-10-06 |
2019-04-24 |
Merck Sharp & Dohme Corp. |
ANTIBODY-ACTIVE CONJUGATE FOR ANTI-INFLAMMATORY APPLICATIONS
|
|
EP3407916B1
(en)
|
2016-01-29 |
2023-12-20 |
Merck Sharp & Dohme LLC |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
US11786603B2
(en)
|
2016-02-26 |
2023-10-17 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
KR102626498B1
(ko)
|
2016-03-25 |
2024-01-19 |
씨젠 인크. |
페길화된 약물-링커 및 그의 중간체의 제조를 위한 공정
|
|
GB201608936D0
(en)
|
2016-05-20 |
2016-07-06 |
Polytherics Ltd |
Novel conjugates and novel conjugating reagents
|
|
PE20190622A1
(es)
|
2016-06-02 |
2019-04-26 |
Abbvie Inc |
Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
|
|
WO2017214458A2
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
MA46417A
(fr)
|
2016-09-23 |
2019-07-31 |
Regeneron Pharma |
Anticorps anti-steap2, conjugués anticorps-médicament, et molécules bispécifiques de liaison à l'antigène qui se lient à steap2 et cd3, et leurs utilisations
|
|
KR20250114431A
(ko)
|
2016-11-08 |
2025-07-29 |
리제너론 파마슈티칼스 인코포레이티드 |
스테로이드 및 이의 단백질-접합체
|
|
CN116785450A
(zh)
|
2017-02-28 |
2023-09-22 |
伊缪诺金公司 |
具有自分解肽接头的类美登素衍生物和其缀合物
|
|
AU2018269568B2
(en)
|
2017-05-18 |
2022-03-24 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
KR20200007905A
(ko)
|
2017-05-18 |
2020-01-22 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
CN118652192A
(zh)
|
2017-05-24 |
2024-09-17 |
德克萨斯州大学系统董事会 |
用于抗体药物缀合物的接头
|
|
CN108853514B
(zh)
|
2017-08-18 |
2022-07-22 |
四川百利药业有限责任公司 |
具有两种不同药物的抗体药物偶联物
|
|
WO2019034176A1
(zh)
|
2017-08-18 |
2019-02-21 |
四川百利药业有限责任公司 |
一种喜树碱-抗体偶联物
|
|
IL313068A
(en)
|
2017-11-07 |
2024-07-01 |
Regeneron Pharma |
Hydrophilic linkers for antibody drug conjugates
|
|
MA49796A
(fr)
|
2017-12-01 |
2020-06-03 |
Abbvie Inc |
Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci
|
|
IL275757B2
(en)
|
2018-01-08 |
2025-08-01 |
Regeneron Pharma |
Steroids and antibody-conjugates thereof
|
|
BR112020020466A2
(pt)
|
2018-04-06 |
2021-01-12 |
Seattle Genetics, Inc. |
Conjugados de peptídeo de camptotecina
|
|
MX2020011546A
(es)
|
2018-05-09 |
2021-01-29 |
Regeneron Pharma |
Anticuerpos anti-msr1 y metodos de uso de los mismos.
|
|
SG11202105175WA
(en)
|
2018-11-20 |
2021-06-29 |
Regeneron Pharma |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
CA3123607A1
(en)
|
2018-12-21 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
WO2020146541A2
(en)
|
2019-01-08 |
2020-07-16 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
|
US20230119539A1
(en)
|
2019-01-08 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
